Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
ElSayed NA, et al
[1] [2] This once-weekly injectable medication works by enhancing insulin secretion in response to meals, suppressing glucagon release, and slowing gastric emptying, which collectively improve glycemic control and promote weight loss
It also helps lower blood sugar levels and improves insulin sensitivity in type 2 diabetics (3)
Cagrilintide + Semaglutide is a fixed dose combination of a long acting amylin analogue and a GLP 1 receptor agonist, studied as CagriSema in adults with overweight or obesity, with and without type 2 diabetes
Retatrutide remains under regulatory review in early-phase trials, with ongoing studies evaluating safety, efficacy, and long-term therapeutic potential
US$ 27.24
US$ 26.07
US$ 28.37
US$ 20.19
US$ 25.94
US$ 26.46
